Возраст домена | 24 года |
Дата окончания | Через 3 года |
PR | 6 |
ИКС | 10 |
Страниц в Google | 5450 |
Страниц в Яндексе | 5000 |
Dmoz | Да |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 4677783 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Home - Acta Pharmacologica Sinica
materia medica, chinese academy of sciences, neuropharmacology, clinical pharmacology
Acta Pharmacologica Sinica published monthly in English, is the official journal of the Chinese Pharmacological Society and Shanghai Institute of Materia Medica, Chinese Academy of Sciences.
UTF-8
54.93 КБ
1 019
8 677 симв.
7 439 симв.
Идет сбор информации... Обновить
Идет сбор информации... Обновить
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Идет сбор информации... Обновить
Внешние ссылки главной страницы ( 12 ) | |
mc.manuscriptcentral.com/aphs | - |
nature.com/aps/focuses | Special Issue |
nature.com/aps/journal/vaop/ncurrent/index.html | Advance Online Publication (AOP) |
nature.com/articles/aps201833 | Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy – an illustra... |
nature.com/articles/aps20185 | Discovery and development of NA-1 for the treatment of acute ischemic stroke |
nature.com/aps/journal/vaop/ncurrent/abs/aps20172a.html | Therapeutic gene editing: delivery and regulatory perspectives |
nature.com/aps/journal/vaop/ncurrent/abs/aps201744a.html | Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immun... |
english.simm.cas.cn/ | <img> |
cnphars.org/ | <img> |
nature.com/aps/index.html | <img> |
publicationethics.org/ | <img> |
amegroups.com | AME Publishing Company |
Внутренние ссылки главной страницы ( 32 ) | |
chinaphar.com/login | Log In |
chinaphar.com/user/register | Register |
/ | - |
chinaphar.com/search | Advanced Search |
chinaphar.com/index | Home |
chinaphar.com/about | About the Journal |
chinaphar.com/about/editorInChief | Jian Ding |
chinaphar.com/about/editorialTeam | Editorial Board |
chinaphar.com/pages/view/acknowledgementToReviewers | Acknowledgements |
/pages/view/aps-instruction-for-authors | Author Instruction |
/public/system/aps/aps-licence-to-publish.pdf | Licence to Publish |
/public/system/aps/aps-licence-to-publish-open-access-option... | Open Access Option |
chinaphar.com/issue/archive | Archives |
chinaphar.com/announcement | more |
chinaphar.com/pages/view/Contact-US | Contact Us |
chinaphar.com/announcement/view/148 | More >> |
chinaphar.com/article/view/9882 | Emerging roles of sphingosylphosphorylcholine in modulating cardiovascular functions and diseases |
chinaphar.com/article/view/9895 | Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy |
chinaphar.com/issue/current/showToc | Vol 40, No 10 (October, 2019) |
chinaphar.com/article/view/10031 | Interplay between Alzheimer’s disease and global glucose metabolism revealed by the metabolic profile alterations of pancreatic ... |
chinaphar.com/article/view/10032 | Curculigoside facilitates fear extinction and prevents depression-like behaviors in a mouse learned helplessness model through i... |
chinaphar.com/article/view/10033 | Nitazoxanide, an anti-parasitic drug, efficiently ameliorates learning and memory impairments in AD model mice |
chinaphar.com/article/view/10034 | The oncometabolite 2-hydroxyglutarate inhibits microglial activation via the AMPK/mTOR/NF-κB pathway |
chinaphar.com/article/view/10035 | /CAMK II/ERK/NF-κB signaling pathway |
chinaphar.com/article/view/10036 | Irisin exerts a therapeutic effect against myocardial infarction via promoting angiogenesis |
chinaphar.com/article/view/10037 | Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4... |
chinaphar.com/article/view/10038 | Identification of PRDX6 as a regulator of ferroptosis |
chinaphar.com/article/view/10039 | retinoic acid prevents cancer initiation and stemness in osteosarcoma cells |
chinaphar.com/article/view/10040 | root extract: human pharmacokinetics of ginsenosides and potential for perpetrating drug interactions |
chinaphar.com/article/view/10041 | Structure-based design of a hyperthermostable AgUricase for hyperuricemia and gout therapy |
chinaphar.com/announcement/view/147 | More >> |
chinaphar.com/announcement/view/146 | More >> |
Domain Name: CHINAPHAR.COM
Registry Domain ID: 10490552_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.sfn.cn
Registrar URL: http://www.sfn.cn
Updated Date: 2018-05-21T05:31:03Z
Creation Date: 1999-09-21T09:46:17Z
Registry Expiry Date: 2027-09-21T09:46:17Z
Registrar: Beijing Sanfront Information Technology Co., Ltd
Registrar IANA ID: 1588
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: ok https://icann.org/epp#ok
Name Server: DNSP.SIBSNET.ORG
Name Server: DNSS.SIBSNET.ORG
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-12-11T01:08:48Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
User-agent: *
Allow: /
Allow: /search/authors
Allow: /*/search/authors
Disallow: /search
Disallow: /*/search
Disallow: /login
Disallow: /user/register
Disallow: /*/login
Disallow: /*/user/register
Disallow: /tools
Sitemap: http://www.amepc.org/index/sitemap
Япония - Токио - 47.74.40.41
Nortel Networks
Nortel Networks
HTTP/1.1 200 OK
Server: nginx
Date: Sat, 19 Oct 2019 09:01:13 GMT
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
Vary: Accept-Encoding
Vary: Accept-Encoding
X-Powered-By: PHP/5.5.9-1ubuntu4.29
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"